A Second Manufacturer Just Told Nevada Not to Use its Drugs for Executions

The state’s deputy solicitor general called the move “ironic.”

Hailshadow/Getty

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

Another pharmaceutical company doesn’t want Nevada to use its drug to execute Scott Dozier. On Monday, a district judge approved a motion filed by Hikma, the manufacturer of the powerful opioid fentanyl, to join the lawsuit filed by Alvogen, the maker of the controversial sedative midazolam. Midazolam has been blamed for several botched executions in the past and was going to be part of a three-drug combination used to execute Dozier. His scheduled execution in July was put on hold after Alvogen filed suit. 

Hikma is arguing that the company specifically told Nevada in 2016 that its drugs could not be used for an execution. Alvogen made similar claims in its lawsuit, accusing the state of secretly obtaining the drug despite the company’s warnings that it does not approve of the use of its drugs for lethal injections. The third component of Nevada’s three-drug protocol is a muscle paralyzer that medical professionals said could mask the inmate’s pain during an execution.

Dozier has been on death row since 2007 for the 2002 murder of Jeremiah Miller. Beginning in 2016, he gave up any effort to appeal his sentence, and maintained that he wanted to be put to death. Just hours before Dozier was set to die on July 11, a district judge issued a temporary restraining order blocking the state from using the midazolam. In response, Nevada filed a petition with the Nevada Supreme Court, asking that the decision that halted the execution be thrown out and accusing Alvogen of mounting a public relations campaign. “[Alvogen] filed this lawsuit to salvage its image and shift the blame to the State for Alvogen’s failure to impose the controls that it was touting to anti-death penalty advocates,” the petition says. The state Supreme Court is now considering the petition.

Nevada now has to contend with yet another manufacturer and in response leveled similarly harsh criticism for Hikma, implying that it was attempting to distract attention from a far bigger problem. The deputy solicitor general called it “ironic that the maker of fentanyl, which is at the center of the nation’s opioid crisis and is responsible for illegal overdoses every day is going to…claim reputational injury from being associated with a lawful execution.” 

But some states still plan to use these drugs. Carey Moore, who is set to die in Nebraska on August 14, will likely now be the first person executed with the powerful painkiller. The state intends to use the opioid in a four-drug protocol to execute the inmate, who shot and killed Maynard Helgeland and Reuel Van Ness five days apart in 1979. Nebraska has come under fire for refusing to disclose where its lethal injection drugs came from despite court orders to do so. 

Assuming that the drugs were manufactured by Pfizer, Independent Nebraska state Sen. Ernie Chambers, a long time anti-death penalty advocateurged the company to follow in Alvogen’s footsteps and sue the state in order to have the drugs returned and the execution halted. But the company said it had no records of Nebraska obtaining restricted drugs and was not going to file a lawsuit. “So where did the governor get his drugs?” Chambers wrote on Facebook after Pfizer declined to sue the state. “He’s not saying, and he’s refusing to obey the courts who have ordered him to share the information.”

WHO DOESN’T LOVE A POSITIVE STORY—OR TWO?

“Great journalism really does make a difference in this world: it can even save kids.”

That’s what a civil rights lawyer wrote to Julia Lurie, the day after her major investigation into a psychiatric hospital chain that uses foster children as “cash cows” published, letting her know he was using her findings that same day in a hearing to keep a child out of one of the facilities we investigated.

That’s awesome. As is the fact that Julia, who spent a full year reporting this challenging story, promptly heard from a Senate committee that will use her work in their own investigation of Universal Health Services. There’s no doubt her revelations will continue to have a big impact in the months and years to come.

Like another story about Mother Jones’ real-world impact.

This one, a multiyear investigation, published in 2021, exposed conditions in sugar work camps in the Dominican Republic owned by Central Romana—the conglomerate behind brands like C&H and Domino, whose product ends up in our Hershey bars and other sweets. A year ago, the Biden administration banned sugar imports from Central Romana. And just recently, we learned of a previously undisclosed investigation from the Department of Homeland Security, looking into working conditions at Central Romana. How big of a deal is this?

“This could be the first time a corporation would be held criminally liable for forced labor in their own supply chains,” according to a retired special agent we talked to.

Wow.

And it is only because Mother Jones is funded primarily by donations from readers that we can mount ambitious, yearlong—or more—investigations like these two stories that are making waves.

About that: It’s unfathomably hard in the news business right now, and we came up about $28,000 short during our recent fall fundraising campaign. We simply have to make that up soon to avoid falling further behind than can be made up for, or needing to somehow trim $1 million from our budget, like happened last year.

If you can, please support the reporting you get from Mother Jones—that exists to make a difference, not a profit—with a donation of any amount today. We need more donations than normal to come in from this specific blurb to help close our funding gap before it gets any bigger.

payment methods

WHO DOESN’T LOVE A POSITIVE STORY—OR TWO?

“Great journalism really does make a difference in this world: it can even save kids.”

That’s what a civil rights lawyer wrote to Julia Lurie, the day after her major investigation into a psychiatric hospital chain that uses foster children as “cash cows” published, letting her know he was using her findings that same day in a hearing to keep a child out of one of the facilities we investigated.

That’s awesome. As is the fact that Julia, who spent a full year reporting this challenging story, promptly heard from a Senate committee that will use her work in their own investigation of Universal Health Services. There’s no doubt her revelations will continue to have a big impact in the months and years to come.

Like another story about Mother Jones’ real-world impact.

This one, a multiyear investigation, published in 2021, exposed conditions in sugar work camps in the Dominican Republic owned by Central Romana—the conglomerate behind brands like C&H and Domino, whose product ends up in our Hershey bars and other sweets. A year ago, the Biden administration banned sugar imports from Central Romana. And just recently, we learned of a previously undisclosed investigation from the Department of Homeland Security, looking into working conditions at Central Romana. How big of a deal is this?

“This could be the first time a corporation would be held criminally liable for forced labor in their own supply chains,” according to a retired special agent we talked to.

Wow.

And it is only because Mother Jones is funded primarily by donations from readers that we can mount ambitious, yearlong—or more—investigations like these two stories that are making waves.

About that: It’s unfathomably hard in the news business right now, and we came up about $28,000 short during our recent fall fundraising campaign. We simply have to make that up soon to avoid falling further behind than can be made up for, or needing to somehow trim $1 million from our budget, like happened last year.

If you can, please support the reporting you get from Mother Jones—that exists to make a difference, not a profit—with a donation of any amount today. We need more donations than normal to come in from this specific blurb to help close our funding gap before it gets any bigger.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate